International pharmaceutical companies and well-known research centers have entered a race against time since the outbreak of the new Corona virus to produce an effective vaccine.
Dozens of companies and research centers in various countries of the world have so far announced that they are close to producing a vaccine for a virus CoronaFew of them actually reached the third stage of the experiments, which then gives them approval for approval by the responsible authorities in the countries.
The World Health Organization said, in a previous report, that “the goal is for each country to be able to vaccinate 20% of its population by the end of 2021,” meaning that the world needs approximately 3 billion doses for about 1.5 billion people in 2021.
The competition has passed the stage of active substances and has reached expected price wars for the vaccine itself, as the Russian vaccine manufacturer Sputnik V revealed that the price of its Coronavirus vaccine will be much lower than the price of the American vaccines for Pfizer, which reached about $ 20, and the Moderna vaccine, which reached 39 Dollars a dose.
And the company’s Twitter account wrote: The price of the Sputnik V will be much lower.
The Chairman of the Board of Directors of Moderna, Nubar Avian, confirmed that a billion dollars had been invested in the search for a vaccine for the emerging corona virus.
The Chairman of the Board of Directors of Moderna added: We cooperated with the administration of the outgoing US President Donald Trump on the financial and logistical level.
And he continued: The American elections had no effect on efforts to provide the vaccine.
The size of the vaccine market
Because of the global anticipation of the vaccine, some pharmaceutical companies, according to the British Guardian newspaper, expect that the size of the Corona vaccine market will reach about $ 25 billion annually.
The number relates largely to the stability, spread and diversification of the price of vaccines, not in its early stages, which will witness global competition to purchase the first doses of it.
According to Morgan Stanley, the annual vaccination of the needy in the world, for vaccine prices ranging between 3 and 37 dollars per dose, will generate revenues of 10 billion dollars annually for the pharmaceutical industry in the United States, Europe and developed countries alone.
Countries are racing
Rich countries have so far contracted most of the vaccines expected to be produced, especially from Moderna and Pfizer, while the rest of the countries have contracted with Russian and Chinese companies.
According to the pre-purchase agreements signed with “Pfizer”, there are 1.1 billion doses purchased by rich countries, out of a total of 1.3 billion doses expected to be produced by the end of next year, when the United States alone requested about 600 million doses from the company.
The European Union announced the purchase of about 300 million doses of the “Pfizer” and “Biontech” vaccine, without announcing the value of the deal, and the two companies said that deliveries are expected to begin by the end of this year.
Britain announced in advance that it had seized 40 million doses of the Pfizer vaccine, of which 10 million doses may be available before the end of this year, while Israeli Prime Minister Benjamin Netanyahu announced that he had signed an agreement with Pfizer to buy 8 million vaccines.
Moderna, which received $ 2.5 billion from the US government, promised to provide 100 million doses for Americans, including 15 million before the end of December.
Moderna has signed contracts with Canada, Switzerland, Qatar, Japan and Israel, and is negotiating with the European Union, Britain and the international Kovacs program.
Moderna intends to produce 20 million doses this year and between 500 million and a billion in 2021 thanks to production sites and industrial partners in the United States, Switzerland and Spain.
While the Chinese “Sinopharma” group promised to supply Indonesia with 40 million doses of the same “Corona Vaccine” vaccine by March 2021, while Brazil, one of the countries most affected by the coronavirus, also agreed to buy 46 million doses of the Chinese vaccine.
The chief executive of the Russian Direct Investment Fund, Kirill Dmitriev, said earlier that Russia had received requests from 20 countries to supply it with two billion doses of the “Sputnik V” vaccine.
The Russian “Kommersant” newspaper reported, earlier, that a medical center, which is the largest in Israel, had applied for the purchase of 1.5 million doses of the vaccine.
These were the details of the news The price exchange for Corona vaccines is burning … Sputnik is... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.